258 related articles for article (PubMed ID: 17341060)
1. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.
Helguera AM; Rodríguez-Borges JE; García-Mera X; Fernández F; Cordeiro MN
J Med Chem; 2007 Apr; 50(7):1537-45. PubMed ID: 17341060
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of Antineoplastic Activity of Novel Carbocyclic Nucleosides.
Helguera AM; Rodríguez-Borges JE; Caamaño O; García-Mera X; González MP; Cordeiro MN
Mol Inform; 2010 Mar; 29(3):213-31. PubMed ID: 27462765
[TBL] [Abstract][Full Text] [Related]
3. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives.
Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y
J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516
[TBL] [Abstract][Full Text] [Related]
4. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
5. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
6. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
7. Stochastic entropy QSAR for the in silico discovery of anticancer compounds: prediction, synthesis, and in vitro assay of new purine carbanucleosides.
González-Díaz H; Viña D; Santana L; de Clercq E; Uriarte E
Bioorg Med Chem; 2006 Feb; 14(4):1095-107. PubMed ID: 16253507
[TBL] [Abstract][Full Text] [Related]
8. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners.
Naik PK; Alam A; Malhotra A; Rizvi O
J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR of histone deacetylase inhibitors as anticancer agents by genetic function approximation.
Wagh NK; Deokar HS; Juvale DC; Kadam SS; Kulkarni VM
Indian J Biochem Biophys; 2006 Dec; 43(6):360-71. PubMed ID: 17285800
[TBL] [Abstract][Full Text] [Related]
11. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
12. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
14. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
[TBL] [Abstract][Full Text] [Related]
15. ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds.
González-Díaz H; Bonet I; Terán C; De Clercq E; Bello R; García MM; Santana L; Uriarte E
Eur J Med Chem; 2007 May; 42(5):580-5. PubMed ID: 17207560
[TBL] [Abstract][Full Text] [Related]
16. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
Oloff S; Mailman RB; Tropsha A
J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
[TBL] [Abstract][Full Text] [Related]
17. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
Xiao Z; Varma S; Xiao YD; Tropsha A
J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
19. Ensemble feature selection: consistent descriptor subsets for multiple QSAR models.
Dutta D; Guha R; Wild D; Chen T
J Chem Inf Model; 2007; 47(3):989-97. PubMed ID: 17407280
[TBL] [Abstract][Full Text] [Related]
20. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
